Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins

PURPOSE: Although preclinical, epidemiological and prior clinical trial data suggest that green tea catechins (GTCs) may reduce prostate cancer (PCa) risk, several preclinical studies and case reports have reported liver toxicities and acute gastrointestinal bleeding. Based on these observations, re...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Nagi B., Pow-Sang, Julio, Spiess, Philippe E., Park, Jong, Salup, Raoul, Williams, Christopher R., Parnes, Howard, Schell, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340117/
https://www.ncbi.nlm.nih.gov/pubmed/28053292
http://dx.doi.org/10.18632/oncotarget.12222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340117/
https://www.ncbi.nlm.nih.gov/pubmed/28053292
http://dx.doi.org/10.18632/oncotarget.12222

Ejemplares similares